MuscleLedger

Collagen Peptides Benefits, Endpoint by Endpoint: What Was Measured, Against What, and by Whom

Collagen peptides are credited with muscle, joint, tendon, bone and skin benefits. Each claim rests on a handful of trials. This index lists the main trial behind each, what it measured, what the comparison group took, and who ran it.

Leon H · Edited by Caroline S · Published 2026-10-03

Illustration: A stack of petri dishes on a concrete lab bench under cool light.
Illustration

"Collagen benefits" is a list most labels print without dates or trial names: muscle, joints, tendons, bones, skin, sometimes gut and sleep. Each item traces back to a small number of trials. This page is the index. For every endpoint it names the main trial, what it measured, what the comparison group took, and who ran it, because on this supplement those two columns change how much a result means. The deep dives sit on their own pages and are linked rather than repeated.

It reports what trials found and gives no recommendation, per our editorial standards.

The index

Endpoint Main trial Who and how long Result vs comparison Comparison group took Industry link in the record
Muscle mass, with training Zdzieblik 2015 53 men with sarcopenia, mean age 72.2; 12 weeks fat-free mass +4.2 vs +2.9 kg; quadriceps strength +16.5 vs +7.3 Nm silica author at Collagen Research Institute GmbH; 2025 correction: Gelita AG supplied samples and paid participant and analysis costs
Muscle mass, with training (women) Jendricke 2019 77 premenopausal women; 12 weeks larger rise in fat-free mass and hand-grip strength (impedance) placebo none declared
Muscle protein synthesis Oikawa 2020 older women; acute and longer-term tracer longer-term synthesis not raised by collagen; raised by whey whey protein public funding (CIHR)
Muscle thickness and tendon size, with training Jerger 2022 40 young men; 14 weeks tendon area +11.0 vs +4.7%; muscle thickness +7.3 vs +2.7%; stiffness and strength no difference placebo funded by Gelita AG; author at Collagen Research Institute
Joint pain in athletes Clark 2008 97 athletes analysed; 24 weeks six pain measures improved vs placebo, e.g. pain walking −1.11 vs −0.46 xanthan-thickened liquid none in the indexed record
Knee pain in sport Zdzieblik 2017 139 athletes; 12 weeks activity pain −19.5 vs −13.9 VAS points (p = 0.046); rest pain n.s. placebo author at Collagen Research Institute
Bone density König 2018 131 postmenopausal women; 12 months spine T-score +0.10 vs −0.03; femoral neck +0.09 vs −0.01 placebo author at Collagen Research Institute
Collagen-synthesis marker Shaw 2017 8 men, crossover; 3 days 15 g gelatin + vitamin C before exercise doubled a blood marker of collagen synthesis placebo public funding (NIH)
Skin elasticity Proksch 2014 69 women aged 35–55; 8 weeks elasticity improved at 2.5 and 5 g vs placebo placebo co-author S. Oesser, listed at the Collagen Research Institute on the muscle and bone papers

"Industry link in the record" means what PubMed's affiliation, funding and conflict fields show, read on 2026-10-03, plus the published 2025 correction to the sarcopenia trial and author identity across the papers. "None in the indexed record" is not a finding that no link exists.

What the two right-hand columns show

Eight of nine compared collagen with nothing. Every trial except Oikawa 2020 gave the control group an inert placebo: silica, a thickened liquid, or an unnamed placebo. That answers "does collagen beat no protein?". It does not answer "does collagen beat the protein a lifter would otherwise take?", and the one study that asked that question found whey raised muscle protein synthesis and collagen did not. The same point is argued in full on collagen peptides for muscle growth and, for recovery trials, on collagen peptides for muscle recovery.

Five of nine carry an industry link. Four list a co-author from the Collagen Research Institute GmbH in Kiel (the same researcher, S. Oesser, appears on the skin trial), the Achilles trial lists Gelita AG, a collagen manufacturer, as funder, and a 2025 correction to the most-cited muscle trial states that Gelita supplied its samples and paid for participant compensation and analysis (PMID 40859798); that correction is read in full on how much collagen per day. Most of the positive muscle, tendon, joint and bone results come from one group at the University of Freiburg working with that institute. Industry involvement does not make a result wrong. It does mean the field has not yet been replicated at arm's length on most of these endpoints.

The pooled analysis cannot see past its inputs. A 2026 network meta-analysis of 78 trials and 4,755 participants ranked collagen first of 13 protein supplements against placebo, for strength (SMD 0.41, 95% CI 0.09 to 0.73) and for fat-free mass (SMD 0.94, 95% CI 0.48 to 1.40) (Drummond 2026). A network meta-analysis ranks treatments through the comparisons its trials made. When nearly every collagen trial was against an inert placebo and whey's were often against other proteins, collagen competes with nothing and whey with something. The ranking is reported here as published, with that caveat.

Endpoint notes, one paragraph each

Muscle. The positive trials paired collagen with supervised resistance training and measured fat-free mass, which includes water and connective tissue as well as muscle. The tracer study measured muscle protein built, and collagen did not move it in the longer term. Both findings stand; they measure different things. Collagen's protein-quality score under US labelling rules is zero, because it lacks tryptophan, which is why its gram line and its Percent Daily Value disagree; that rule is explained on collagen vs whey protein.

Joints. Both joint trials enrolled athletes with activity-related pain and no diagnosed joint disease. Both used pain scales, which are sensitive to expectation, and in the Freiburg trial pain at rest did not separate from placebo. No trial in this index imaged cartilage. This site's peptides for joints and tendons covers the research peptides sold for the same complaint, where the human evidence is thinner still.

Tendon. The Achilles result is a size result. Tendon stiffness, the mechanical property closer to function and injury risk, rose in both groups with no difference between them. No trial here counted injuries.

Bone. The bone trial is the longest in the index (12 months) and used dual-energy X-ray absorptiometry, the standard instrument. The T-score changes are small (a tenth of a standard deviation on the spine), and no fractures were measured.

Collagen synthesis. The vitamin C and gelatin study is the source of the "take it an hour before training" idea. It had eight participants, lasted three days and measured a blood marker, not tissue. Its timing is examined on how much collagen per day.

Skin. One 8-week trial reported better elasticity. Skin is outside this site's beat; Peptide Glow Journal's page on collagen peptides for hair and skin covers it.

Not in the index. Gut, sleep, hair and nails appear on labels; no trial on those endpoints was read for this page, so none is graded here.

Safety, in one line

Collagen peptide trials report few adverse events, and most never measured them systematically. The plausible risks (a hydroxyproline-to-oxalate pathway relevant to kidney stones, fish and bovine allergy, gut upset at large doses) are read on collagen side effects.

How much the trials used

Reported, not recommended: 15 g a day in the muscle trials, 5–10 g in the joint trials, 5 g in the tendon and bone trials, 2.5–5 g in the skin trial. The median US collagen-peptide powder label puts 11 g in a scoop. Both are set out side by side on how much collagen per day. People combining it with creatine will find what the trials did, and did not, test on creatine and collagen peptides.

The honest summary

  • Muscle: more fat-free mass with training vs no protein; no longer-term rise in muscle protein synthesis vs whey.
  • Joints: less activity pain in athletes without joint disease (two trials, pain scales).
  • Tendon: larger Achilles cross-section, same stiffness (one trial, industry-funded).
  • Bone: a small T-score rise over 12 months in postmenopausal women; no fracture data.
  • Comparators: 8 of 9 inert. Industry links: 5 of 9.

Limits of this page

This is an index of the main trial per endpoint, chosen because each is the one cited most often on this site's deep-dive pages; it is not a systematic review, and other trials exist for most endpoints. Industry links were read from PubMed's affiliation, funding and conflict fields and one published correction, not from every full-text acknowledgement, so the count is a floor. Effect sizes are as reported in each abstract.

Sources and dates

  • Zdzieblik D, Oesser S, Baumstark MW, Gollhofer A, König D. Collagen peptide supplementation in combination with resistance training improves body composition and increases muscle strength in elderly sarcopenic men. Br J Nutr 2015;114:1237–45 — PMID 26353786; correction Br J Nutr 2025;134:440 — PMID 40859798
  • Jendricke P, Centner C, Zdzieblik D, Gollhofer A, König D. Specific collagen peptides in combination with resistance training improve body composition and regional muscle strength in premenopausal women. Nutrients 2019;11:892 — PMID 31010031
  • Oikawa SY, Kamal MJ, Webb EK, et al. Whey protein but not collagen peptides stimulate acute and longer-term muscle protein synthesis with and without resistance exercise in healthy older women. Am J Clin Nutr 2020;111:708–18 — PMID 31919527
  • Jerger S, Centner C, Lauber B, et al. Effects of specific collagen peptide supplementation combined with resistance training on Achilles tendon properties. Scand J Med Sci Sports 2022;32:1131–41 — PMID 35403756
  • Clark KL, Sebastianelli W, Flechsenhar KR, et al. 24-week study on the use of collagen hydrolysate as a dietary supplement in athletes with activity-related joint pain. Curr Med Res Opin 2008;24:1485–96 — PMID 18416885
  • Zdzieblik D, Oesser S, Gollhofer A, König D. Improvement of activity-related knee joint discomfort following supplementation of specific collagen peptides. Appl Physiol Nutr Metab 2017;42:588–95 — PMID 28177710
  • König D, Oesser S, Scharla S, Zdzieblik D, Gollhofer A. Specific collagen peptides improve bone mineral density and bone markers in postmenopausal women — a randomized controlled study. Nutrients 2018;10:97 — PMID 29337906
  • Shaw G, Lee-Barthel A, Ross ML, Wang B, Baar K. Vitamin C-enriched gelatin supplementation before intermittent activity augments collagen synthesis. Am J Clin Nutr 2017;105:136–43 — PMID 27852613
  • Proksch E, Segger D, Degwert J, et al. Oral supplementation of specific collagen peptides has beneficial effects on human skin physiology: a double-blind, placebo-controlled study. Skin Pharmacol Physiol 2014;27:47–55 — PMID 23949208
  • Drummond MDM, Silva RAD, Junior NC, et al. Which protein-based dietary supplements most effectively enhance fat-free mass and strength gains in healthy adults undergoing resistance training? A systematic review and network meta-analysis. Transl Sports Med 2026:5557511 — PMID 41635649
  • PubMed affiliation, grant and conflict-of-interest fields for all nine primary papers, read via E-utilities 2026-10-03.

Frequently asked questions

What are the proven benefits of collagen peptides?

None is proven in the sense of being replicated by independent groups against an active comparator. The best-supported findings are small: more fat-free mass and strength when added to resistance training in older men and in women, less activity-related knee pain in athletes, a larger Achilles tendon cross-section with training, and a small rise in bone density in postmenopausal women. Most come from one research group, most used an inert placebo, and several have industry-affiliated authors.

Do collagen peptides build muscle?

Against a placebo with no protein, trials report more fat-free mass with training (4.2 vs 2.9 kg in older men). Against whey, a tracer study found collagen did not raise longer-term muscle protein synthesis. The two results answer different questions: collagen versus nothing, and collagen versus a complete protein. This site's page on collagen peptides for muscle growth reads both.

Do collagen peptides help joints?

Two trials in athletes reported less activity-related joint pain: 97 athletes analysed over 24 weeks at Penn State (10 g a day) and 139 athletes over 12 weeks in Freiburg (5 g a day). Neither studied people with diagnosed joint disease, and pain at rest did not differ significantly in the Freiburg trial.

Do collagen peptides help tendons?

One trial in 40 young men found a larger increase in Achilles tendon cross-sectional area with 5 g a day plus 14 weeks of heavy training (11.0% vs 4.7%). Tendon stiffness, the property that relates to function, rose equally in both groups. The trial was funded by a collagen manufacturer.

Are collagen peptides good for bones?

One 12-month trial in 131 postmenopausal women with low bone density found small increases in spine and hip T-scores with 5 g a day versus placebo. No trial in this index measured fractures. One author is listed at a collagen research institute.

Are collagen peptides good for skin?

An 8-week trial in 69 women aged 35 to 55 found improved skin elasticity at 2.5 and 5 g a day versus placebo. Skin is outside this site's scope; Peptide Glow Journal's page on collagen peptides for hair and skin covers that evidence.

How much collagen did the trials use?

Reported, not recommended: 15 g a day in the muscle trials, 5 to 10 g in the joint trials, 5 g in the tendon and bone trials, and 2.5 to 5 g in the skin trial. This site's page on how much collagen per day lays out each trial's amount against what US labels put in a scoop.